InvestorsHub Logo
Followers 62
Posts 1561
Boards Moderated 0
Alias Born 01/31/2014

Re: MI Dendream post# 439077

Thursday, 01/27/2022 11:39:15 AM

Thursday, January 27, 2022 11:39:15 AM

Post# of 704187
MiD, Excellent look into the long term survival rate at 5 years.

I especially like this

What are we invested in an ancient pharma with little pipeline and future headwinds or should our multiple valuation look more like a burgeoning biotech with a deep pipeline and novel approaches to disease with high unmet medical need, very, very high unmet need.


Who knows, the DCVax platform may go along the horizontal growth rate by treating one additional cancer at a time. But what if the platform can also grow along the vertical, has exponential potential. Flipper brought up the idea possibility of treating virus infections. We are talking about DCVax making smarter the most powerful treatment in existence and forever, our immune system. There is "no toxicity" so no limits as a potential treatment option. Sorry, this is over my head a bit, but I have to babble out my excitement.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News